Page 1 of Clinical Trials for Drug RCHOP, 92 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
Last Updated: September 14, 2011
Condition(s): Lymphoma
2
Recruiting
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
Last Updated: January 11, 2012
Condition(s): Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
3
Withdrawn
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
Last Updated: December 28, 2011
Condition(s): Chronic Lymphocytic Leukaemia; Patients Resistant to a Purine Analogous; Patients Relapsed With Purines Therapy
4
Terminated
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
Last Updated: April 12, 2012
Condition(s): Non-Hodgkin's Lymphoma; B-cell Lymphoma
5
Recruiting
Risk Stratified Sequential Treatment for CD20-positive PTLD
Last Updated: October 18, 2011
Condition(s): PTLD; Posttransplant Lymphoproliferative Disorder
6
Not yet recruiting
A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
Last Updated: May 18, 2012
Condition(s): CD20-positive B-cell Non-Hodgkin Lymphoma
7
Recruiting
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
Last Updated: January 3, 2012
Condition(s): Lymphoma, Mantle-Cell
8
Active, not recruiting
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
Last Updated: May 16, 2012
Condition(s): Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
9
Active, not recruiting
Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Last Updated: January 13, 2012
Condition(s): Mantle Cell Lymphoma
10
Completed
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Last Updated: November 23, 2009
Condition(s): HIV Infections; Diffuse Large B Cell Lymphoma
11
Completed
Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Last Updated: September 22, 2011
Condition(s): Lymphoma; Diffuse Large Cell
12
Not yet recruiting
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
Last Updated: July 7, 2009
Condition(s): Lymphoma
13
Recruiting
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
Last Updated: May 2, 2012
Condition(s): Lymphoma
14
Active, not recruiting
Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Last Updated: January 13, 2012
Condition(s): Diffuse Large B-Cell Lymphoma
15
Active, not recruiting
Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Last Updated: February 22, 2012
Condition(s): Lymphoma
16
Recruiting
Efficacy of Rituximab - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Versus R-CHOP/R-DHAP in Patients With Untreated Mantle Cell Lymphoma
Last Updated: July 16, 2009
Condition(s): Lymphoma, Mantle-Cell
17
Recruiting
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Last Updated: April 5, 2011
Condition(s): Lymphoma
18
Recruiting
Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy
Last Updated: April 25, 2012
Condition(s): Diffuse Large B-cell Lymphoma; Follicle Center Lymphoma
19
Recruiting
Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Last Updated: July 23, 2011
Condition(s): Lymphoma
20
Recruiting
Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, Prednisone, Rituximab, Pegfilgrastim, and Sargramostim as Front-Line Therapy in Treating Patients With Aggressive Non-Hodgkin Lymphoma
Last Updated: February 15, 2011
Condition(s): Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+RCHOP

Page 1 of Clinical Trials for Drug RCHOP, 92 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About